Stock Trend Analysis Report
Prepared for you on Tuesday, October 3, 2023.
Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)
Long-Term Downtrend (-90) - AVIR is in a strong downtrend that is likely to continue. While AVIR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid AVIR?
MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for AVIR
The long-term trend has been DOWN since Sep 6th, 2023 at 3.26
The intermediate-term trend has been DOWN since Jun 21st, 2023 at 3.97
The short-term trend has been DOWN since Sep 14th, 2023 at 3.27
Smart Scan Analysis for AVIR
Based on our trend formula, AVIR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||6.32||52wk High Date||2022-11-01|
|52wk Low||2.88||52wk Low Date||2023-10-02|
|Average Volume||454,433||Shares Outstanding||83,399|